Discover the 2017 agenda

TRACK 1 – NEW PLAYERS INVOLVED IN INNOVATION IN THE HEALTH SECTOR

TRACK 2 – NURTURING AND LICENSING EARLY-STAGE ASSETS

TRACK 3 – BIOENTREPRENEURS’ CHALLENGES AT PRE-SEED, SEED AND SERIES A STAGES


DAY ONE – 28th Nov. 2017

Conferences and roundtable discussions

Presentation sessions

Partnering

Hosted event

8.30am
9.30am

WELCOME COFFEE

LM 3

9.30am
11.00am

How can collaborations in rare diseases be an asset in a highly competitive and fast moving market?

Shared risk or competition for emerging assets: How can we optimise pharma-VC relationships?

Licensing Opportunity Presentations

Biofit-01

One-to-one meetings
&

SIMV

R&D dating for animal health and innovation

Translational research at Medalis: From lab to biotech

11.00am
11.30am

NETWORKING BREAK

BREAK

11.30am
1.00pm

PLENARY SESSION

How can we overcome the shortage
of bioentrepreneurs in Europe?

1.00pm
2.30pm

LUNCH

LUNCH

2.30pm
4.00pm

Exploring the growing relationship between pharma, digital health companies and data providers

Assessing the opportunity for licensing early-stage projects

Start-up Slams

Biofit-01

One-to-one meetings

Early projects, early opportunity: Find your match

4.00pm
4.30pm

NETWORKING BREAK

&

BREAK

4.30pm
6.00pm

How are focused therapeutic funds becoming increasingly important at pre-seed, seed and Series A stages?

Workshop: A closer look at early-stage collaborations in the UK

Licensing Opportunity Presentations

SIMV

R&D dating for animal health and innovation

Nature and nurture of an Academic drug discovery Centre

6.30pm

BIOPARTY


DAY TWO – 29th Nov. 2017

Conferences and roundtable discussions

Presentation sessions

Partnering

8.30am
9.00am

WELCOME COFFEE

9.00am
10.30am

How are collaborations key to improve innovation in metabolic diseases?

How to keep the founding scientists committed?

Start-up Slams

10.30am
11.00am

NETWORKING BREAK

11.00am
12.30pm

How can animal innovation and human innovation / applications be mutually beneficial?

Where will European
pre-seed, seed and Series A investment go in 2018?

Licensing Opportunity Presentations

Biofit-01

One-to-one meetings

12.30pm
2.00pm

LUNCH

&

2.00pm
3.30pm

How can TTOs increase their role in the early development of spin-offs?

Are venture philanthropy and trusts emerging in the initial stages of funding?

Start-up Slams

SIMV

R&D dating for animal health and innovation

3.30pm
4.00pm

How can we define a mutually beneficial collaboration between an academic institution and a resulting spin-off?

Award ceremony

4.00pm
4.30pm

4.30pm
5.00pm

CLOSING COFFEE BREAK

5.00pm
6.00pm